Levetas 500mg Tablet contains Levetiracetam, an antiepileptic medication indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in adults and pediatric patients. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is believed to inhibit abnormal neuronal firing. This mechanism helps to stabilize electrical activity in the brain, reducing seizure frequency and severity. Levetas is typically prescribed as adjunctive therapy but may also be used as monotherapy depending on clinical assessment. The tablet is administered orally, with dosing individualized based on patient age, renal function, and therapeutic response. Common adverse effects include somnolence, dizziness, headache, and fatigue, though it is generally well tolerated. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Levetas should be used under medical supervision, with regular monitoring for efficacy and potential side effects. It is contraindicated in patients with known hypersensitivity to Levetiracetam or any excipients. Patients are advised to avoid abrupt discontinuation to prevent seizure exacerbation. This medication does not cure epilepsy but helps manage symptoms effectively when used as directed.